Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Miniature tumor organoids could help guide treatment decisions for people with rare cancers

UCLA scientists have developed a new method to quickly screen hundreds of drugs in order to identify treatments that can target specific tumors.

26 Feb 2019

'Chromosome scanner' that protects against cancer identified

In a new study, researchers from the University of Copenhagen have identified one of the main mechanisms behind the repair of serious damage to the human DNA. A 'scanner' inside the cells decides whether or not so-called flawless DNA repair, which protects against cancer, is launched.

26 Feb 2019

New analysis highlights increasing focus of early-stage clinical trials on rare cancers

The proportion of early-stage drug trials tackling the biggest cancer killers has declined sharply since the early 1990s as less common tumor types receive increasing attention, according to new research to be presented during the International Congress on Targeted Anticancer Therapies 2019, taking place from today to 27 February in Paris, France.

25 Feb 2019

Breast cancer study: Family-history-based models perform better than non-family-history based models

A team of researchers led by Columbia University Mailman School of Public Health Professor Mary Beth Terry, PhD, evaluated four commonly used breast cancer prediction models and found that family-history-based models perform better than non-family-history based models, even for women at average or below-average risk of breast cancer.

22 Feb 2019

New identified biomarker predicts patients who might benefit from HER2-targeted agents

In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy.

22 Feb 2019

New software found to be four times better at predicting the prognosis of ovarian cancer

A new tool has proved to be four times more reliable at predicting prognosis in patients with ovarian cancer and the most effective course of treatment.

18 Feb 2019

Vapers develop cancer-related gene deregulation as cigarette smokers

If you think vaping is benign, think again. A small USC study shows that e-cig users develop some of the same cancer-related molecular changes in oral tissue as cigarette smokers, adding to the growing concern that e-cigs aren't a harmless alternative to smoking.

15 Feb 2019

Artificial intelligence can accurately predict prognosis of ovarian cancer patients

The artificial intelligence software, created by researchers at Imperial College London and the University of Melbourne, has been able to predict the prognosis of patients with ovarian cancer more accurately than current methods. It can also predict what treatment would be most effective for patients following diagnosis.

15 Feb 2019

Trojan Horse approach to cancer therapy shows promise

A new form of cancer fighting drug has been developed using the principles of the “Trojan Horse”.

11 Feb 2019

New cancer drug that acts as ‘Trojan horse’ shows promise in patients with various cancers

A brand new type of cancer drug that acts as a 'Trojan horse' to get inside tumor cells has shown promise in patients with six different cancer types.

11 Feb 2019

Non-cancerous ovarian cysts need not be removed surgically, suggests study

Women may not need to undergo surgery for non-cancerous ovarian cysts, avoiding potential surgical complications.

5 Feb 2019

Drug treating breast cancer may be effective in treating lung and ovarian cancer

Two new papers, published simultaneously in Nature Communications and led by researchers at McGill University, offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer, one rare and one common form.

5 Feb 2019

Study: Maternal age, body mass index, race affect hormone concentrations in pregnancy

Hormone concentrations during early fetal development -- that may affect the child's development and increase the mother's risk for breast and ovarian cancer years later -- are significantly affected by maternal age, body mass index and race rather than lifestyle, according to a Rutgers study.

5 Feb 2019

New path toward improving effectiveness of chemotherapy in breast, ovarian cancer

People who inherit a faulty copy of the so-called "breast cancer genes" BRCA1 and BRCA2 are at high risk of cancer. About 10 percent of breast cancer cases and 15 percent of ovarian cancers can be traced back to a flaw in one of these genes.

5 Feb 2019

Cancer among Israeli men on the decline says report

According to a report from the Israel Cancer Association yesterday (3rd February 2019), there has been a significant fall in the number of Israeli men getting cancers over that last decade.

3 Feb 2019

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

The Damon Runyon Cancer Research Foundation announced that nine scientists with novel approaches to fighting cancer have been named 2019 recipients of the Damon Runyon-Rachleff Innovation Award.

24 Jan 2019

New anti-inflammatory compound acts as 'surge protector' to reduce cancer growth

A new anti-inflammatory compound developed at the University of California, Davis, acts as a "surge protector" to suppress inflammation and reduce cancer growth, at least in mouse models of cancer.

17 Jan 2019

Research reveals novel approach to suppressing chemotherapy-induced tumor growth

Following up on a groundbreaking 2018 study in which BIDMC's Dipak Panigrahy, MD, demonstrated that dead and dying cancer cells killed by conventional cancer treatments paradoxically trigger inflammation that promotes tumor growth and metastasis, a new study led by Allison Gartung, PhD, describes a novel approach to suppressing chemotherapy-induced tumor growth in an ovarian cancer model.

16 Jan 2019

Hypertension drug may improve effectiveness of ovarian cancer treatment

A new study from a Massachusetts General Hospital research team has found that the hypertension drug losartan, which targets the angiotensin signaling pathway, may improve the effectiveness of chemotherapy agents used to treat ovarian cancer

16 Jan 2019

Aggressive prostate cancer linked to hereditary breast cancer, confirms study

Aggressive prostate cancer, one of the leading causes of cancer deaths in men, is associated with BRCA2 mutations, which are also linked to hereditary breast cancer, ovarian cancer and pancreas cancer, among others.

10 Jan 2019

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Miniature tumor organoids could help guide treatment decisions for people with rare cancers

'Chromosome scanner' that protects against cancer identified

New analysis highlights increasing focus of early-stage clinical trials on rare cancers

Breast cancer study: Family-history-based models perform better than non-family-history based models

New identified biomarker predicts patients who might benefit from HER2-targeted agents

New software found to be four times better at predicting the prognosis of ovarian cancer

Vapers develop cancer-related gene deregulation as cigarette smokers

Artificial intelligence can accurately predict prognosis of ovarian cancer patients

Trojan Horse approach to cancer therapy shows promise

New cancer drug that acts as ‘Trojan horse’ shows promise in patients with various cancers

Non-cancerous ovarian cysts need not be removed surgically, suggests study

Drug treating breast cancer may be effective in treating lung and ovarian cancer

Study: Maternal age, body mass index, race affect hormone concentrations in pregnancy

New path toward improving effectiveness of chemotherapy in breast, ovarian cancer

Cancer among Israeli men on the decline says report

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

New anti-inflammatory compound acts as 'surge protector' to reduce cancer growth

Research reveals novel approach to suppressing chemotherapy-induced tumor growth

Hypertension drug may improve effectiveness of ovarian cancer treatment

Aggressive prostate cancer linked to hereditary breast cancer, confirms study

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in